Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.

Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol BRNS
- Company Barinthus Biotherapeutics plc
- Price $1.5
- Changes Percentage -2.12
- Change -0.03
- Day Low $1.33
- Day High $1.6
- Year High $2.92
- Year Low $0.64
- Market Cap $60,412,278
- Price Avg 50 EMA (D) $0.97
- Price Avg 200 EMA (D) $1.03
- Exchange NASDAQ
- Volume 391,094
- Average Volume 1,199,191
- Open $1.6
- Previous Close $1.53
- EPS -1.64
- PE -0.91
- Earnings Announcement 2025-08-06 12:30:00
- Shares Outstanding $40,339,395
Company brief: BARINTHUS BIOTHERAPEUTICS PLC (BRNS )
- Healthcare
- Biotechnology
- Mr. William J. Enright MBA
- https://www.barinthusbio.com
- GB
- N/A
- 04-30-2021
- US91864C1071
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. It is advancing a pipeline of product candidates across a range of therapeutic areas, including VTP-300, an immunotherapeutic candidate designed as a potential component of a functional cure for chronic HBV infection; VTP-200, a non-surgical product candidate for persistent high-risk human papillomavirus (HPV); VTP-1000, an autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease; VTP-850, a second-generation immunotherapeutic candidate designed to treat recurrent prostate cancer; and VTP-1100, a preclinical cancer candidate designed to utilize the SNAP-CI platform to treat patients with HPV-related cancer. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is headquartered in Harwell, the United Kingdom.